- Q4 2023 Knight Therapeutics Inc Earnings Call TranscriptMar 21, 2024C$5.23 (-2.97%)Earnings
- Q3 2023 Knight Therapeutics Inc Earnings Call TranscriptNov 09, 2023C$4.99 (+4.39%)Earnings
- Q2 2023 Knight Therapeutics Inc Earnings Call TranscriptAug 10, 2023C$4.84 (+0.21%)Earnings
- Q1 2023 Knight Therapeutics Inc Earnings Call TranscriptMay 11, 2023C$4.81 (+2.12%)Earnings
- Knight Therapeutics Inc Annual Shareholders Meeting TranscriptMay 10, 2023
- Q4 2022 Knight Therapeutics Inc Earnings Call TranscriptMar 23, 2023C$4.84 (-1.22%)Earnings
- Q3 2022 Knight Therapeutics Inc Earnings Call TranscriptNov 10, 2022C$5.31 (-1.67%)Earnings
- Q2 2022 Knight Therapeutics Inc Earnings Call TranscriptAug 11, 2022C$5.97 (+7.37%)Earnings
- Q1 2022 Knight Therapeutics Inc Earnings Call TranscriptMay 12, 2022C$5.19 (-0.57%)Earnings
- Knight Therapeutics Inc Annual Shareholders Meeting TranscriptMay 11, 2022
- Q4 2021 Knight Therapeutics Inc Earnings Call TranscriptMar 24, 2022C$5.22 (-6.12%)Earnings
- Q3 2021 Knight Therapeutics Inc Earnings Call TranscriptNov 11, 2021C$5.29 (+0.76%)Earnings
- Q2 2021 Knight Therapeutics Inc Earnings Call TranscriptAug 13, 2021C$5.6 (+8.95%)Earnings
- Q1 2021 Knight Therapeutics Inc Earnings Call TranscriptMay 14, 2021C$5.35 (+1.90%)Earnings
- Knight Therapeutics Inc Host A Conference Call To Discuss The Exelon Acquisition TranscriptApr 23, 2021
- Q4 2020 Knight Therapeutics Inc Earnings Call TranscriptMar 25, 2021C$5.23 (+4.81%)Earnings
- Q3 2020 Knight Therapeutics Inc Earnings Call TranscriptNov 13, 2020C$5.39 (-0.37%)Earnings
- Q2 2020 Knight Therapeutics Inc Earnings Call TranscriptAug 13, 2020C$6.75 (+0.45%)Earnings
- Q1 2020 Knight Therapeutics Inc Earnings Call TranscriptJun 26, 2020C$6.82 (-6.19%)Earnings
- Knight Therapeutics Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q4 2019 Knight Therapeutics Inc Earnings Call TranscriptMar 30, 2020C$6.13 (+2.34%)Earnings
- Q3 2019 Knight Therapeutics Inc Earnings Call TranscriptNov 12, 2019C$8.08 (-1.70%)Earnings
- Knight Therapeutics Inc M&A Call TranscriptOct 21, 2019
- Q2 2019 Knight Therapeutics Inc Earnings Call TranscriptAug 08, 2019C$7.44 (+0.81%)Earnings
- Q1 2019 Knight Therapeutics Inc Earnings Call TranscriptMay 09, 2019C$7.47 (-0.40%)Earnings
- Q4 2018 Knight Therapeutics Inc Earnings Call TranscriptMar 14, 2019C$7.55 (+0.27%)Earnings
Q3 2021 Knight Therapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen. My name is Liane, and I will be your operator today. Welcome to Knight Therapeutics Inc. 2021 Third Quarter Financial Results Conference Call.
Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautious that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries, may ultimately prove to be incorrect. The company disclaims any intention or obligation to update or revise any forward-looking statements whether a result of new information or future events, except as required by law.
We would also like to remind you that questions during today's call will be taken from analysts only. Should there
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)